Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
195 hedge funds and large institutions have $841M invested in Avid Bioservices, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 40 closing their positions.
2,180% more call options, than puts
Call options by funds: $3.21M | Put options by funds: $141K
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
65% more first-time investments, than exits
New positions opened: 66 | Existing positions closed: 40
14% more funds holding
Funds holding: 171 → 195 (+24)
9% more capital invested
Capital invested by funds: $772M → $841M (+$69M)
8% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
+$42.6M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$29.3M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$22.3M |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
+$21.2M |
| 5 |
WIC
Water Island Capital
New York
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$43.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.4M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$31.5M |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$22.3M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$18.8M |
CDMO Hedge Fund Activity: Q4 2024 in Review
195 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2024, worth a combined $841M — up 8.9% from $772M a quarter earlier.
Buyers outnumbered sellers: 66 funds opened new CDMO positions and 40 closed out — a net gain of 26 holders — while 47 added to existing stakes and 51 trimmed.
The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $42.6M. The largest seller was Millennium Management, cutting an estimated $43.7M.
- 195 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2024, up from 171 in Q3 2024.
- Funds reported $841M of Avid Bioservices, Inc. Common Stock stock for Q4 2024, up 8.9% quarter-over-quarter.
- 66 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2024 and 40 closed out, a net change of +26 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2024 was Glazer Capital LLC, an estimated $42.6M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q4 2024 was Millennium Management, an estimated $43.7M sold.
Based on aggregated 13F filings for Q4 2024.